Description

MC-Gly-Gly-Phe-Gly-amide-cyclopropanol-amide-Exatecan is a pharmaceutical composition containing antibody agent conjugate (ADC). (extracted from patent WO2021190581 Example 1-8)[1].–20°C (Powder, sealed storage, away from moisture)-Applications-Cancer-programmed cell death-Formula-C54H58FN9O13-Citation–References-[1]Yue Zhanlong, et al. Pharmaceutical composition comprising antibody drug conjugate and use thereof. WO2021190581A1.-CASNumber-2414254-41-2-MolecularWeight-1060.09-Compound Purity-99.48-SMILES-O=C(C1(CC1)OCNC(CNC([C@@H](NC(CNC(CNC(CCCCCN2C(C=CC2=O)=O)=O)=O)=O)CC3=CC=CC=C3)=O)=O)N[C@@H]4C5=C6C(C(N7C6)=CC([C@](O)(C(OC8)=O)CC)=C8C7=O)=NC9=CC(F)=C(C)C(CC4)=C95-Research_Area-Cancer-Solubility-DMSO : 60 mg/mL (ultrasonic;warming;heat to 60°C)-Target-Drug-Linker Conjugates for ADC;Topoisomerase-Isoform-Camptothecins-Pathway-Antibody-drug Conjugate/ADC Related;Cell Cycle/DNA Damage-MCE Product type-ADC Related